Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Turid Aas

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Oncology Reports|February 12, 2005
Prognostic and predictive value of changes in tumour cell proliferation in locally advanced breast cancer primarily treated with doxorubicinTurid Aas, Stephanie Geisler, Hildegunn Helle, et al.
Breast Cancer Research and Treatment|September 3, 2013
Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatmentErnst A Lien, Håvard Søiland, Steinar Lundgren, et al.
BMC Cancer|February 20, 2025
The impact of functional MDM2-polymorphisms on neutrophil counts in breast cancer patients during neoadjuvant chemotherapyNora D Hatletvedt, Christina Engebrethsen, Jürgen Geisler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levelsJürgen Geisler, Hilgegunn Helle, Dagfinn Ekse, et al.
Plos One|February 16, 2017
Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancerSura Aziz, Elisabeth Wik, Gøril Knutsvik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancerStephanie Geisler, Anne-Lise Børresen-Dale, Hilde Johnsen, et al.
Plos One|March 9, 2016
Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast CancerSura Aziz, Elisabeth Wik, Gøril Knutsvik, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|December 25, 2014
Illness uncertainty in breast cancer patients: validation of the 5-item short form of the Mishel Uncertainty in Illness ScaleKari Britt Hagen, Turid Aas, Kirsten Lode, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancerKarin Collett, Geir E Eide, Jarle Arnes, et al.
Scientific Reports|February 15, 2025
Distinct clinicopathological features and treatment differences in breast cancer patients of young ageRasmus O C Humlevik, Amalie A Svanøe, Turid Aas, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Oncology Reports|February 12, 2005
Prognostic and predictive value of changes in tumour cell proliferation in locally advanced breast cancer primarily treated with doxorubicinTurid Aas, Stephanie Geisler, Hildegunn Helle, et al.
Breast Cancer Research and Treatment|September 3, 2013
Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatmentErnst A Lien, Håvard Søiland, Steinar Lundgren, et al.
BMC Cancer|February 20, 2025
The impact of functional MDM2-polymorphisms on neutrophil counts in breast cancer patients during neoadjuvant chemotherapyNora D Hatletvedt, Christina Engebrethsen, Jürgen Geisler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levelsJürgen Geisler, Hilgegunn Helle, Dagfinn Ekse, et al.
Plos One|February 16, 2017
Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancerSura Aziz, Elisabeth Wik, Gøril Knutsvik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancerStephanie Geisler, Anne-Lise Børresen-Dale, Hilde Johnsen, et al.
Plos One|March 9, 2016
Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast CancerSura Aziz, Elisabeth Wik, Gøril Knutsvik, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|December 25, 2014
Illness uncertainty in breast cancer patients: validation of the 5-item short form of the Mishel Uncertainty in Illness ScaleKari Britt Hagen, Turid Aas, Kirsten Lode, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancerKarin Collett, Geir E Eide, Jarle Arnes, et al.
Scientific Reports|February 15, 2025
Distinct clinicopathological features and treatment differences in breast cancer patients of young ageRasmus O C Humlevik, Amalie A Svanøe, Turid Aas, et al.
Pageof 5